Medistim ASA Total Assets
Medistim ASA total assets. Based on the latest financial reports, Medistim ASA (MEDI) holds total assets worth Nkr535.04 Million NOK (≈ $56.30 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Medistim ASA stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Medistim ASA (2004–2024)
Total assets of Medistim ASA from 2004 to 2024. This chart illustrates how Medistim ASA's total assets have evolved over time, based on quarterly financial data. See Medistim ASA (MEDI) stock price for real-time trading data and today's change.
Medistim ASA - Asset Composition Analysis
Medistim ASA Total Assets Breakdown (December 2024)
Medistim ASA total assets breakdown as of December 2024. Medistim ASA's total assets of Nkr535.04 Million consist of 74.6% current assets and 25.4% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr0.00 | 31.2% |
| Accounts Receivable | Nkr68.98 Million | 12.0% |
| Inventory | Nkr160.52 Million | 27.9% |
| Property, Plant & Equipment | Nkr73.16 Million | 12.7% |
| Intangible Assets | Nkr55.61 Million | 9.7% |
| Goodwill | Nkr14.13 Million | 2.5% |
Asset Composition Trend (2004–2024)
This chart illustrates how Medistim ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Medistim ASA current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medistim ASA's current assets represent 74.6% of total assets in 2024, a decrease from 79.8% in 2004.
- Cash Position: Cash and equivalents constituted 31.2% of total assets in 2024, down from 36.3% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, unchanged from 11.0% in 2004.
- Asset Diversification: The largest asset category is inventory at 27.9% of total assets.
Medistim ASA Competitors by Total Assets
Key competitors of Medistim ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Medistim ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.14 | 4.42 | 4.71 |
| Quick Ratio | 1.73 | 2.40 | 2.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Nkr264.33 Million | Nkr279.05 Million | Nkr229.56 Million |
Medistim ASA - Advanced Valuation Insights
This section examines the relationship between Medistim ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.52 |
| Latest Market Cap to Assets Ratio | 1.02 |
| Asset Growth Rate (YoY) | 13.7% |
| Total Assets | Nkr574.97 Million |
| Market Capitalization | $586.47 Million USD |
Valuation Analysis
Above Book Valuation: The market values Medistim ASA's assets above their book value (1.02x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Medistim ASA's assets grew by 13.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medistim ASA (2004–2024)
The table below shows the annual total assets of Medistim ASA from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr574.97 Million ≈ $60.50 Million |
+13.69% |
| 2023-12-31 | Nkr505.72 Million ≈ $53.22 Million |
+4.78% |
| 2022-12-31 | Nkr482.66 Million ≈ $50.79 Million |
+19.69% |
| 2021-12-31 | Nkr403.24 Million ≈ $42.43 Million |
+16.61% |
| 2020-12-31 | Nkr345.82 Million ≈ $36.39 Million |
+2.89% |
| 2019-12-31 | Nkr336.11 Million ≈ $35.37 Million |
+24.67% |
| 2018-12-31 | Nkr269.59 Million ≈ $28.37 Million |
+7.38% |
| 2017-12-31 | Nkr251.06 Million ≈ $26.42 Million |
+15.67% |
| 2016-12-31 | Nkr217.05 Million ≈ $22.84 Million |
-0.63% |
| 2015-12-31 | Nkr218.44 Million ≈ $22.99 Million |
+7.35% |
| 2014-12-31 | Nkr203.49 Million ≈ $21.41 Million |
+20.84% |
| 2013-12-31 | Nkr168.39 Million ≈ $17.72 Million |
+10.88% |
| 2012-12-31 | Nkr151.87 Million ≈ $15.98 Million |
+1.50% |
| 2011-12-31 | Nkr149.63 Million ≈ $15.74 Million |
+2.52% |
| 2010-12-31 | Nkr145.94 Million ≈ $15.36 Million |
+0.22% |
| 2009-12-31 | Nkr145.63 Million ≈ $15.32 Million |
+0.17% |
| 2008-12-31 | Nkr145.38 Million ≈ $15.30 Million |
+12.88% |
| 2007-12-31 | Nkr128.79 Million ≈ $13.55 Million |
+8.09% |
| 2006-12-31 | Nkr119.15 Million ≈ $12.54 Million |
+40.18% |
| 2005-12-31 | Nkr85.00 Million ≈ $8.94 Million |
+14.57% |
| 2004-12-31 | Nkr74.19 Million ≈ $7.81 Million |
-- |
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more